| 摘要 |
The present invention describes compounds of formula Iand enantiomers, diastereomers and pharmaceutically acceptable salts thereof.The formula I compounds are protein kinase inhibitors and are useful in the treatment of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease. |
